{"id":1715,"date":"2018-08-23T18:19:11","date_gmt":"2018-08-23T18:19:11","guid":{"rendered":"https:\/\/fehv.org\/?p=1715"},"modified":"2018-08-23T18:23:05","modified_gmt":"2018-08-23T18:23:05","slug":"therapeutic-alternatives-to-control-hepatitis-c","status":"publish","type":"post","link":"https:\/\/fehv.org\/en\/therapeutic-alternatives-to-control-hepatitis-c\/","title":{"rendered":"Therapeutic alternatives to control hepatitis C"},"content":{"rendered":"<p>Therefore, until new drugs appear, it is necessary to look for therapeutic alternatives to control the disease. There are different strategies to achieve this goal.<\/p>\n<p>It has been shown that phlebotomies (blood extraction in a similar amount to donation) can be very effective. With this approach, up to 69% of patients with hepatitis C normalize transaminases, with improvement in liver biopsy and decreased risk of developing liver cancer. Also ursodeoxycholic acid (a drug that decreases liver inflammation) is useful for the treatment of chronic hepatitis C. In several studies it has been shown that this drug at a dose of 20-30 mg \/ kg of weight and per day improves the liver analysis (transaminases) and may decrease the likelihood of liver cancer with few side effects. Also vitamin E, administered orally, can induce normalization of transaminases especially if they have deficit thereof.<\/p>\n<p>There are natural products from plants and fruits (artichoke, grapefruit, blueberries, spirulina) that are not effective in the treatment of chronic hepatitis C despite popular beliefs.<\/p>\n<p>It is also important to correct the metabolic disorders that patients with hepatitis C have since they contribute to increase inflammation of the liver. Thus, if there is an increase in cholesterol, triglycerides or glucose, they should be treated with diet and medications (statins, etc.). It is also important to change the habits of life. For example, obesity worsens hepatitis C and should be corrected with a weight-loss diet. On the other hand, the practice of exercise should be recommended at least 3 hours per week since it has been shown (even without weight loss) that it contributes to reduce inflammation of the liver in hepatitis C. In relation to eating habits, demonstrated that taking 2-4 cups of coffee (with caffeine) a day helps prevent the progression of hepatitis C. Finally, alcohol intake and smoking are totally prohibited because they worsen the disease.<\/p>\n<p>In summary, there are effective actions to control hepatitis C in the absence of antiviral drugs.<\/p>\n","protected":false},"excerpt":{"rendered":"Currently there are antiviral treatments against chronic hepatitis C (pegylated interferon + ribavirin + inhibitors) with a favorable response in 75% of cases. However, these treatments can have important side effects and contraindications for its administration.","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[622],"tags":[],"class_list":["post-1715","post","type-post","status-publish","format-standard","hentry","category-hepatitis-c-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.6 (Yoast SEO v27.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Therapeutic alternatives to control hepatitis C - Cl\u00ednica FEHV<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fehv.org\/en\/therapeutic-alternatives-to-control-hepatitis-c\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Therapeutic alternatives to control hepatitis C\" \/>\n<meta property=\"og:description\" content=\"Currently there are antiviral treatments against chronic hepatitis C (pegylated interferon + ribavirin + inhibitors) with a favorable response in 75% of cases. However, these treatments can have important side effects and contraindications for its administration.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fehv.org\/en\/therapeutic-alternatives-to-control-hepatitis-c\/\" \/>\n<meta property=\"og:site_name\" content=\"Cl\u00ednica FEHV\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/clinicaFEHV\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-08-23T18:19:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-08-23T18:23:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fehv.org\/wp-content\/uploads\/2018\/07\/Aternativas-terapeuticas-hepatitid-C-500x500.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"ifranco\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ifranco\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fehv.org\\\/en\\\/therapeutic-alternatives-to-control-hepatitis-c\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fehv.org\\\/en\\\/therapeutic-alternatives-to-control-hepatitis-c\\\/\"},\"author\":{\"name\":\"ifranco\",\"@id\":\"https:\\\/\\\/fehv.org\\\/#\\\/schema\\\/person\\\/5e92ddd4a04516dab21fb5b6fa90b777\"},\"headline\":\"Therapeutic alternatives to control hepatitis C\",\"datePublished\":\"2018-08-23T18:19:11+00:00\",\"dateModified\":\"2018-08-23T18:23:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fehv.org\\\/en\\\/therapeutic-alternatives-to-control-hepatitis-c\\\/\"},\"wordCount\":330,\"publisher\":{\"@id\":\"https:\\\/\\\/fehv.org\\\/#organization\"},\"articleSection\":[\"Hepatitis-C\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fehv.org\\\/en\\\/therapeutic-alternatives-to-control-hepatitis-c\\\/\",\"url\":\"https:\\\/\\\/fehv.org\\\/en\\\/therapeutic-alternatives-to-control-hepatitis-c\\\/\",\"name\":\"Therapeutic alternatives to control hepatitis C - Cl\u00ednica FEHV\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fehv.org\\\/#website\"},\"datePublished\":\"2018-08-23T18:19:11+00:00\",\"dateModified\":\"2018-08-23T18:23:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fehv.org\\\/en\\\/therapeutic-alternatives-to-control-hepatitis-c\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fehv.org\\\/en\\\/therapeutic-alternatives-to-control-hepatitis-c\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fehv.org\\\/en\\\/therapeutic-alternatives-to-control-hepatitis-c\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/fehv.org\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Therapeutic alternatives to control hepatitis C\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fehv.org\\\/#website\",\"url\":\"https:\\\/\\\/fehv.org\\\/\",\"name\":\"Cl\u00ednica FEHV\",\"description\":\"Web de la Cl\u00ednica de la Fundaci\u00f3n para el Estudio de las Hepatitis Virales\",\"publisher\":{\"@id\":\"https:\\\/\\\/fehv.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fehv.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/fehv.org\\\/#organization\",\"name\":\"Fundaci\u00f3n para el Estudio de las Hepatitis Virales - FEHV\",\"url\":\"https:\\\/\\\/fehv.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/fehv.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/fehv.org\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/logo_fib-4.png\",\"contentUrl\":\"https:\\\/\\\/fehv.org\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/logo_fib-4.png\",\"width\":47,\"height\":73,\"caption\":\"Fundaci\u00f3n para el Estudio de las Hepatitis Virales - FEHV\"},\"image\":{\"@id\":\"https:\\\/\\\/fehv.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/clinicaFEHV\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fehv.org\\\/#\\\/schema\\\/person\\\/5e92ddd4a04516dab21fb5b6fa90b777\",\"name\":\"ifranco\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a420f8de9a7d1d8c59aac0d97d817361feea70d815889a4d807921618ae04918?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a420f8de9a7d1d8c59aac0d97d817361feea70d815889a4d807921618ae04918?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a420f8de9a7d1d8c59aac0d97d817361feea70d815889a4d807921618ae04918?s=96&d=mm&r=g\",\"caption\":\"ifranco\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Therapeutic alternatives to control hepatitis C - Cl\u00ednica FEHV","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fehv.org\/en\/therapeutic-alternatives-to-control-hepatitis-c\/","og_locale":"en_US","og_type":"article","og_title":"Therapeutic alternatives to control hepatitis C","og_description":"Currently there are antiviral treatments against chronic hepatitis C (pegylated interferon + ribavirin + inhibitors) with a favorable response in 75% of cases. However, these treatments can have important side effects and contraindications for its administration.","og_url":"https:\/\/fehv.org\/en\/therapeutic-alternatives-to-control-hepatitis-c\/","og_site_name":"Cl\u00ednica FEHV","article_publisher":"https:\/\/www.facebook.com\/clinicaFEHV\/","article_published_time":"2018-08-23T18:19:11+00:00","article_modified_time":"2018-08-23T18:23:05+00:00","og_image":[{"width":500,"height":500,"url":"https:\/\/fehv.org\/wp-content\/uploads\/2018\/07\/Aternativas-terapeuticas-hepatitid-C-500x500.jpg","type":"image\/jpeg"}],"author":"ifranco","twitter_card":"summary_large_image","twitter_misc":{"Written by":"ifranco","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fehv.org\/en\/therapeutic-alternatives-to-control-hepatitis-c\/#article","isPartOf":{"@id":"https:\/\/fehv.org\/en\/therapeutic-alternatives-to-control-hepatitis-c\/"},"author":{"name":"ifranco","@id":"https:\/\/fehv.org\/#\/schema\/person\/5e92ddd4a04516dab21fb5b6fa90b777"},"headline":"Therapeutic alternatives to control hepatitis C","datePublished":"2018-08-23T18:19:11+00:00","dateModified":"2018-08-23T18:23:05+00:00","mainEntityOfPage":{"@id":"https:\/\/fehv.org\/en\/therapeutic-alternatives-to-control-hepatitis-c\/"},"wordCount":330,"publisher":{"@id":"https:\/\/fehv.org\/#organization"},"articleSection":["Hepatitis-C"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/fehv.org\/en\/therapeutic-alternatives-to-control-hepatitis-c\/","url":"https:\/\/fehv.org\/en\/therapeutic-alternatives-to-control-hepatitis-c\/","name":"Therapeutic alternatives to control hepatitis C - Cl\u00ednica FEHV","isPartOf":{"@id":"https:\/\/fehv.org\/#website"},"datePublished":"2018-08-23T18:19:11+00:00","dateModified":"2018-08-23T18:23:05+00:00","breadcrumb":{"@id":"https:\/\/fehv.org\/en\/therapeutic-alternatives-to-control-hepatitis-c\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fehv.org\/en\/therapeutic-alternatives-to-control-hepatitis-c\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fehv.org\/en\/therapeutic-alternatives-to-control-hepatitis-c\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/fehv.org\/en\/"},{"@type":"ListItem","position":2,"name":"Therapeutic alternatives to control hepatitis C"}]},{"@type":"WebSite","@id":"https:\/\/fehv.org\/#website","url":"https:\/\/fehv.org\/","name":"Cl\u00ednica FEHV","description":"Web de la Cl\u00ednica de la Fundaci\u00f3n para el Estudio de las Hepatitis Virales","publisher":{"@id":"https:\/\/fehv.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fehv.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/fehv.org\/#organization","name":"Fundaci\u00f3n para el Estudio de las Hepatitis Virales - FEHV","url":"https:\/\/fehv.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fehv.org\/#\/schema\/logo\/image\/","url":"https:\/\/fehv.org\/wp-content\/uploads\/2021\/03\/logo_fib-4.png","contentUrl":"https:\/\/fehv.org\/wp-content\/uploads\/2021\/03\/logo_fib-4.png","width":47,"height":73,"caption":"Fundaci\u00f3n para el Estudio de las Hepatitis Virales - FEHV"},"image":{"@id":"https:\/\/fehv.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/clinicaFEHV\/"]},{"@type":"Person","@id":"https:\/\/fehv.org\/#\/schema\/person\/5e92ddd4a04516dab21fb5b6fa90b777","name":"ifranco","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a420f8de9a7d1d8c59aac0d97d817361feea70d815889a4d807921618ae04918?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a420f8de9a7d1d8c59aac0d97d817361feea70d815889a4d807921618ae04918?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a420f8de9a7d1d8c59aac0d97d817361feea70d815889a4d807921618ae04918?s=96&d=mm&r=g","caption":"ifranco"}}]}},"_links":{"self":[{"href":"https:\/\/fehv.org\/en\/wp-json\/wp\/v2\/posts\/1715","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fehv.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fehv.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fehv.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fehv.org\/en\/wp-json\/wp\/v2\/comments?post=1715"}],"version-history":[{"count":4,"href":"https:\/\/fehv.org\/en\/wp-json\/wp\/v2\/posts\/1715\/revisions"}],"predecessor-version":[{"id":1719,"href":"https:\/\/fehv.org\/en\/wp-json\/wp\/v2\/posts\/1715\/revisions\/1719"}],"wp:attachment":[{"href":"https:\/\/fehv.org\/en\/wp-json\/wp\/v2\/media?parent=1715"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fehv.org\/en\/wp-json\/wp\/v2\/categories?post=1715"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fehv.org\/en\/wp-json\/wp\/v2\/tags?post=1715"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}